SATURDAY, FEBRUARY 21

• Keynote Session 4
• Major Symposia 9-10
  • Major Symposium 9: Dendritic Cells in Immune Responses to Cancer
  • Major Symposium 10: Session to be announced
• Closing Keynote Session

Breakfast

7-8 a.m.

Keynote Session 4

8-9 a.m.

• 8 a.m. | Introduction of Keynote Speaker
  Philip D. Greenberg, Fred Hutchinson Cancer Center, Seattle, Washington
• 8:05 a.m. | Fred Ramsdell, Sonoma Biotherapeutics, Seattle, Washington

Break

9-9:15 a.m.

Major Symposia 9-10

9:15-10:45 a.m.

Major Symposium 9: Dendritic Cells in Immune Responses to Cancer

Session Chair: Stefani Spranger, Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts

• 9:20 a.m. | Not all anti-tumor immune responses are alike: How dendritic cells shape anti-tumor T cells
  Stefani Spranger
• 9:40 a.m. | Max Krummel, University of California, San Francisco, California

Short talks selected from highly rated abstracts

Major Symposium 10: T/B Cell Crosstalk in the Tumor Microenvironment in Immune Responses Across Cancers

Session Chair: Tina Cascone, The University of Texas MD Anderson Cancer Center, Houston, Texas

• 9:20 a.m. | Nikhil Joshi, Yale University School of Medicine, New Haven, Connecticut
• 9:40 a.m. | Tullia C. Bruno, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
• 10 a.m. | Anna Dimberg, Uppsala University, Uppsala, Sweden

Break

10:45-11 a.m.

Closing Keynote Session

11 a.m.-12:20 p.m.

• 11:40 a.m. | Introduction of Keynote Speaker
  Antoni Ribas
• 11:45 a.m. | Alexander Marson, University of California, San Francisco, California

Departure

12:20 p.m.